Document is current
Any future updates will be listed below
-
Authors
Wang, Feng
He, Ming-Ming
Wang, Zi-Xian
Li, Su
Jin, Ying
Ren, Chao
Shi, Si-Mei
Bi, Bing-Tian
Chen, Shuang-Zhen
Lv, Zhi-Da
Hu, Jia-Jia
Wang, Zhi-Qiang
Wang, Feng-Hua
Wang, De-Shen
Li, Yu-Hong
Xu, Rui-Hua https://orcid.org/0000-0001-9771-8534
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2014A030312015)
Medical Science and Technology Foundation of Guangdong Province (2015B020232008)
Science and Technology Program of Guangzhou (15570006)
Pearl River Nova Program of Guangzhou (201610010068)
Fundamental Research Funds for the Central Universities (14ykpy40)
National Key Research and Development Program of China (2017YFC1308900)
National Natural Science Foundation of China (81872011)
- License Information
-
More Information
Article History
Received: 15 November 2018
Accepted: 8 May 2019
First Online: 16 May 2019
Ethics approval and consent to participate
: The trial was approved by the Independent Institute Research Ethics Committee at the Sun Yat-sen University Cancer Center prior to initiation. This trial was conducted in accordance with the Declaration of Helsinki, the guidelines for Good Clinical Practice, the European Union Clinical Trial Directive, and local regulations. All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no potential conflicts of interest to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
